Literature DB >> 15261068

Solution properties of amitriptyline and its partitioning into lipid bilayers.

Namita Deo1, T Somasundaran, P Somasundaran.   

Abstract

Solution properties of a drug and its partitioning into lipid bilayers were studied for drug extraction using several different techniques, such as surface tension, zeta potential, ultra filtration and UV-Vis spectroscopy. From the surface tension study it was found that the presence of salt makes the drug molecules more surface-active. Zeta potential revealed the adsorption of the drug into the liposome bilayers to be governed mostly by electrostatic forces. The drug retention volume was expressed as a capacity factor, K, and that was normalized with respect to the amount of the immobilized phospholipids. The K-values for the positively charged drug on the liposomes decreased in the presence of phosphate buffer due to the presence of the oppositely charged ions. The above methods can thus be used to understand the mechanism of drug-membrane interaction and quantification of drug absorption into liposomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261068     DOI: 10.1016/j.colsurfb.2003.10.019

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  3 in total

1.  Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Clark T Hung; Ponisseril Somasundaran
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-28       Impact factor: 5.268

2.  Fluorescence anisotropy, FT-IR spectroscopy and 31-P NMR studies on the interaction of paclitaxel with lipid bilayers.

Authors:  Anand Babu Dhanikula; Ramesh Panchagnula
Journal:  Lipids       Date:  2008-05-06       Impact factor: 1.880

3.  Amitriptyline activates cardiac ryanodine channels and causes spontaneous sarcoplasmic reticulum calcium release.

Authors:  Nagesh Chopra; Derek Laver; Sean S Davies; Björn C Knollmann
Journal:  Mol Pharmacol       Date:  2008-10-09       Impact factor: 4.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.